Chang, Zheng

The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan

Larsson, H., Chang, Z., D'Onofrio, B. M., & Lichtenstein, P. (2014) · Psychological Medicine

Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology

Cited by 364

Serious Transport Accidents in Adults With Attention-Deficit/Hyperactivity Disorder and the Effect of Medication: A Population-Based Study

Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderTraffic and Road Safety

Cited by 293

Childhood attention‐deficit hyperactivity disorder as an extreme of a continuous trait: a quantitative genetic study of 8,500 twin pairs

Larsson, H., Anckarsater, H., Råstam, M., Chang, Z., & Lichtenstein, P. (2012) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 254

Stimulant ADHD medication and risk for substance abuse

Chang, Z., Lichtenstein, P., Halldner, L., D'Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2014) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 225

Attention-deficit/hyperactivity disorder, school performance, and effect of medication

Jangmo, A., Stålhandske, A., Chang, Z., Chen, Q., Almqvist, C., Feldman, I., Bulik, C. M., Lichtenstein, P., D’Onofrio, B., Kuja-Halkola, R., et al. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 213

Developmental Twin Study of Attention Problems: High Heritabilities Throughout Development

Chang, Z., Lichtenstein, P., Asherson, P. J., & Larsson, H. (2013) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 194

ADHD Medication and Substance-Related Problems

Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017) · American Journal of Psychiatry

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 187

Risk factors for interpersonal violence: an umbrella review of meta-analyses

Fazel, S., Smith, E. N., Chang, Z., & Geddes, J. R. (2018) · The British Journal of Psychiatry

Intimate Partner and Family ViolenceCrime Patterns and Interventions

Cited by 185

Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases

Chang, Z., Ghirardi, L., Quinn, P. D., Asherson, P., D’Onofrio, B. M., & Larsson, H. (2019) · Biological Psychiatry

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 175

Autistic-like traits and their association with mental health problems in two nationwide twin cohorts of children and adults

Lundström, S., Chang, Z., Kerekes, N., Gumpert, C. H., Råstam, M., Gillberg, C., Lichtenstein, P., & Anckarsäter, H. (2011) · Psychological Medicine

Autism Spectrum Disorder ResearchSchizophrenia research and treatment

Cited by 174

Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes

Chang, Z., Quinn, P. D., Hur, K., Gibbons, R. D., Sjölander, A., Larsson, H., & D’Onofrio, B. M. (2017) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderTraffic and Road Safety

Cited by 166

Association of psychiatric comorbidity with the risk of premature death among children and adults with attention-deficit/hyperactivity disorder.

Sun, S., Kuja-Halkola, R., Faraone, S. V., D’Onofrio, B. M., Dalsgaard, S., Chang, Z., & Larsson, H. (2019) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 155

Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study

Chang, Z., D’Onofrio, B. M., Quinn, P. D., Lichtenstein, P., & Larsson, H. (2016) · Biological Psychiatry

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 154

Association Between Prescription of Major Psychotropic Medications and Violent Reoffending After Prison Release

Chang, Z., Lichtenstein, P., Långström, N., Larsson, H., & Fazel, S. (2016) · JAMA

Criminal Justice and Corrections AnalysisPsychopathy, Forensic Psychiatry, Sexual Offending

Cited by 130

Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins

Larsson, H., Asherson, P., Chang, Z., Ljung, T., Friedrichs, B., Larsson, J.-O., & Lichtenstein, P. (2013) · Psychological Medicine

Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research

Cited by 118

Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study

Hollis, C., Chen, Q., Chang, Z., Quinn, P. D., Viktorin, A., Lichtenstein, P., D'Onofrio, B., Landén, M., & Larsson, H. (2019) · The Lancet Psychiatry

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 65

Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study

Lagerberg, T., Fazel, S., Sjölander, A., Hellner, C., Lichtenstein, P., & Chang, Z. (2022) · Neuropsychopharmacology

Suicide and Self-Harm StudiesTreatment of Major Depression

Cited by 61

Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: a systematic review and meta-analysis

Li, L., Yao, H., Zhang, L., Garcia‐Argibay, M., Du Rietz, E., Brikell, I., Solmi, M., Cortese, S., Ramos‐Quiroga, J. A., Ribasés, M., et al. (2023) · JCPP Advances

Attention Deficit Hyperactivity DisorderCardiovascular Health and Risk Factors

Cited by 55

The association between type 2 diabetes and attention- deficit/hyperactivity disorder: a systematic review, meta-analysis, and population-based sibling study

Garcia-Argibay, M., Li, L., Du Rietz, E., Zhang, L., Yao, H., Jendle, J., Ramos-Quiroga, J. A., Ribasés, M., Chang, Z., Brikell, I., et al. (2023) · Neuroscience & Biobehavioral Reviews

Attention Deficit Hyperactivity DisorderDiabetes Management and Research

Cited by 52

Oppositional defiant- and conduct disorder-like problems: neurodevelopmental predictors and genetic background in boys and girls, in a nationwide twin study

Kerekes, N., Lundström, S., Chang, Z., Tajnia, A., Jern, P., Lichtenstein, P., Nilsson, T., & Anckarsäter, H. (2014) · PeerJ

Child and Adolescent Psychosocial and Emotional DevelopmentAttention Deficit Hyperactivity Disorder

Cited by 47

Trajectories of healthcare utilization and costs of psychiatric and somatic multimorbidity in adults with childhood ADHD: a prospective register-based study

Du Rietz, E., Jangmo, A., Kuja‐Halkola, R., Chang, Z., D'Onofrio, B. M., Ahnemark, E., Werner‐Kiechle, T., & Larsson, H. (2020) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderChronic Disease Management Strategies

Cited by 39

Association of opioid prescription initiation during adolescence and young adulthood with subsequent substance-related morbidity

Quinn, P. D., Fine, K. L., Rickert, M. E., Sujan, A. C., Boersma, K., Chang, Z., Franck, J., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2020) · JAMA Pediatrics

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 38

Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individuals

Garcia-Argibay, M., Chang, Z., Brikell, I., Kuja-Halkola, R., D'Onofrio, B. M., Lichtenstein, P., Newcorn, J. H., Faraone, S. V., Larsson, H., & Cortese, S. (2025) · The Lancet Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 31

Methylphenidate and short-term cardiovascular risk

Garcia-Argibay, M., Bürkner, P.-C., Lichtenstein, P., Zhang, L., D’Onofrio, B. M., Andell, P., Chang, Z., Cortese, S., & Larsson, H. (2024) · JAMA Network Open

Attention Deficit Hyperactivity DisorderPharmacovigilance and Adverse Drug Reactions

Cited by 31